Found: 6
Select item for more details and to access through your institution.
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 2, p. 112, doi. 10.1002/path.6066
- By:
- Publication type:
- Article
Targeting the β<sub>2</sub>‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
- Published in:
- Journal of Pathology, 2023, v. 259, n. 1, p. 69, doi. 10.1002/path.6020
- By:
- Publication type:
- Article
Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2363, doi. 10.3390/cancers15082363
- By:
- Publication type:
- Article
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1823, doi. 10.3390/cancers11121823
- By:
- Publication type:
- Article
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00303-z
- By:
- Publication type:
- Article
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02250-3
- By:
- Publication type:
- Article